Advertisement Johnson Matthey Fine Chemicals - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Johnson Matthey Fine Chemicals


Johnson Matthey Fine Chemicals

The Johnson Matthey Fine Chemicals Division operates through a comprehensive network of integrated technical resources and extensive expertise to deliver solutions for all your complex chemistry needs. We draw on the combined knowledge of our scientists, a 200-year heritage and portfolio of unique capabilities to supply sustainable products and deliver a collaborative service tailored to customers in the pharmaceutical, agrochemicals and fine chemical industries.

Johnson MattheyAs well as this, Johnson Matthey considers sustainability a high priority and we have made significant progress in reducing material use and production waste as part of our 2017 Sustainability Programme.

Differentiating technologies and facilities

Through a network of state-of-the-art research and development (R&D), kilo lab, pilot scale and large-scale manufacturing facilities, our portfolio of differentiating technologies enable us to provide a broad range of specialised services. We work across eleven global sites spanning Europe, North America and Asia to offer our customers a substantial toolkit for complex chemistries including catalyst technologies, solid form research, manufacturing-scale chromatography and drug-conjugates.

Drug development, discovery and lifecycle management services

We offer a full spectrum of drug development services, from drug discovery through to bulk production, as well as expert analysis and lifecycle management studies. We bring you these services through our four core offerings: Custom Pharma Solutions, Controlled Substances, Catalysts and APIs & Life Cycle Management. By collaborating efficiently across these offerings, we can provide our customers with a broad range of specialised services ensuring their goals aren’t just met but they are surpassed.

Custom pharmaceutical solutions

Johnson MattheyThrough this offering, Johnson Matthey Fine Chemicals provides a full range of bespoke drug development, scale-up and manufacturing services, from pre-clinical and toxicological studies to development and commercial manufacturing. Our expert teams focus on understanding your problem so that we can solve your most challenging chemistries and scale-up problems.

Controlled substances

Our products are extensively used in therapeutic areas including analgesia, CNS disorders and anti-addiction treatments. We have spent over 200 years building our extensive range of opiates and controlled substances and have a deep expertise in handling complex APIs and potent products. This gives us the knowledge to overcome the most challenging chemistries and complex paperwork, ensuring the reliable supply of controlled substance APIs to our customers.


Johnson Matthey Fine Chemicals catalyst offering includes a range of heterogeneous and homogeneous catalysts, chiral catalysts and a range of biocatalysts that can be applied to accelerate reactions and optimise your processes. This helps make your chemistry more efficient, selective and sustainable as well as reducing cost, process steps and waste.

APIs and lifecycle management

We provide an extensive range of APIs and we possess the expertise to develop many more. We are particularly knowledgeable in platinum-based actives and prostaglandins as well as products covering a wide range of therapeutic classes such as anti-cancer, anti-rJohnson Mattheyheumatic, addiction, psychiatric disorders and ophthalmic indications, however, we are continually seeking to expand and increase our API portfolio through collaborative working.

Contact details:
28 Cambridge Science Park
Milton Road
United Kingdom
Tel: 44(0) 1223 226160

Quick Contact Johnson Matthey Fine Chemicals

Biocatalytic Technologies

JMCCT is delighted to provide an ever-growing, unique group of biocatalysts, that enhance the chiral capabilities of our chemo-catalyst technology offering.

This combined portfolio of catalytic technology, allows us to design the most effective synthetic route for our clients.Click here to find out more.

Catalysis and Chiral Tech

We have unmatched expertise and a broad portfolio of heterogeneous, homogenous, chiral and biocatalytic technologies for customers in the pharmaceutical, fine chemical and agrochemical industries.

Suppliers of Refining Services

The refining and recycling facilities we offer our customers are the most comprehensive and advanced precious metal refining facilities in the world.

Successful long-term partnerships are key to Johnson Matthey's philosophy. JMCCT's refining and recycling services has the technology, experience and reputation to refine all platinum group metals from varied feeds. Our array of capabilities, knowledge and methods makes us a suitable partner for your application.Click here for more information.

Catalytic Services

JMCCT's catalysis and chiral technologies provide ample catalyst screening and process development services, to help support customers throughout the development, scale-up and commercial implementation stages of a project.

For more information click here.

JMCCT’s Full Portfolio of Catalytic Technologies

Our portfolio consists of heterogeneous catalysts, homogeneous catalysts, chiral catalysts, biocatalytic technologies, chiral alcohols, ligands, catalytic services, as well as refining facilities.

Heterogeneous catalystsOur precious metal based heterogeneous catalysts are available from gram to commercial scale.Whether you are looking for an off-the-shelf sample or a fully-customised catalyst, JMCCT consistently delivers outstanding product performance. Our manufacturing facilities in the US, UK, India and China, guarantee consistent catalyst supply, regardless of where your process is brought to scale.Homogeneous catalystsWe…

Suppliers of Chiral Alcohols

Our range of chiral alcohols are characterised by high-chemical and enantio-purity, and synthesised by modern biocatalytic technology.

All the compounds are useful as building blocks for the synthesis of intermediates or APIs, and are available from gram to tonne scale.Click here for more information.

Suppliers of Chiral Catalysts

JMCCT's scope of chiral catalysts and ligands for asymmetric hydrogenation, can be used in a variety of ruthenium, rhodium and iridium catalysed reactions.

Our global team of catalysis experts can help you find the optimal solution you are seeking.Click here for more information.


Our extensive capabilities in chromatography range from small-scale GMP studies to large-scale, with up to one metre diameter columns. This is supported by our highly experienced team and impressive infrastructure.

Complex Chemistry Solutions

We effectively plan and execute the development and scale-up processes for linking small molecules payloads to polymers in support of PDCs, ADCs and other drug delivery applications.

Heterogeneous Catalysts

The use of heterogeneous catalyst for chemical production is growing in importance as chemical industries seek to demonstrate improved sustainability and reduced environmental impact. This drive towards the use of heterogeneous catalysts is based on the inherent process benefits on offer. These include easier product isolation and purification, no undesired catalyst derived contamination of the product, cost benefits from catalyst re-cycling and often improved activity and reaction selectivity over homogeneous catalysts, or even stoichiometric homogeneous reagents.

Heterogeneous catalysts, which are highly suitable for either batch or continuous flow applications, can also be used as convenient tools for high throughput discovery chemistry, reducing and often removing the need for laborious product purifications.PhosphonicS has developed a range of novel heterogeneous catalysts for a wide range of applications including metal-mediated cross couplings, oxidations and…

High Containment

We are able to handle various levels of highly potent APIs in R&D, developmental manufacturing and full production settings. Our state-of-the-art facilities are equipped to carry out a wide range of chemical transformations, specialty separations and catalysis.

Suppliers of Homogeneous Catalysts

We provide an exceptional portfolio of innovative palladium catalysts for cross-coupling applications, such as Suzuki, Heck, Buchwald-Hartwig, Kumada, Negishi and Sonogashira.

As well as this, we have a full range of palladium, rhodium, ruthenium and iridium precursors for a variety of chiral and achiral applications.Click here for more information.

Suppliers of Ligands

Our range of proprietary and non-proprietary advanced ligands includes chiral phosphine ligands, chiral transfer hydrogenation ligands, buchwald ligands and cross-coupling ligands.

IP friendly business models allow our customers to have access to the best possible catalytic processes while at the same time ensuring full freedom to operate.Click here for more information.

Solid Form Sciences

Our world leading services include batch profiling, polymorph studies, salt screening/ co-crystallisation, chiral separations and process scale-up, including process control, to ensure your API meets quality standards.

Quick Contact Johnson Matthey Fine Chemicals
Quick Contact Johnson Matthey Fine Chemicals

Johnson Matthey Launches New Online Catalyst Store

West Deptford, N.J. – 11 January 2017, Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients...
11th January 2017

Johnson Matthey’s Annan, UK site receives MHRA certification for GMP manufacturing

The company has made significant investments to refurbish the site, which is now fully equipped for GMP manufacturing
21st September 2016

Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland, UK

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion...
11th December 2015

Johnson Matthey Commissions New High Containment Manufacturing Capacity in Edinburgh, UK

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion...
11th December 2015

Johnson Matthey Rebrands its Fine Chemicals Division

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has today unveiled...
11th December 2015

Johnson Matthey Receives Two Pharmaceutical and Biotech CMO Leaderships Awards 2015

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has been recognised...
11th December 2015

Johnson Matthey Acquires Pharmorphix

Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has acquired the...
11th December 2015

Johnson Matthey Acquires Pharmaceutical Manufacturing Capacity in Scotland

Johnson Matthey, a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an...
3rd December 2014

ACS Announces Dr Thomas Colacot as the Recipient of the 2015 National Award for Industrial Chemistry

Johnson Matthey is pleased to announce that Dr. Thomas Colacot, Global R&D manager of Homogeneous Catalysis for the Johnson Matthey...
12th November 2014

Johnson Matthey Catalysis and Chiral Technologies Expands Ligands Offer; Boosts Buchwald Ligands Manufacturing to Commercial Scale

Matthey (LSE: JMAT) has announced that their global Catalysis and Chiral Technologies technology business unit, JMCCT, which provides trusted expertise...
20th December 2013
Quick Contact Johnson Matthey Fine Chemicals

JM Animation

Published on December 14, 2015
Quick Contact Johnson Matthey Fine Chemicals

Johnson Matthey’s Product Brochure

This case study showcases Johnson Matthey's fine chemical product listings, including palladium, platinum, rhodium, ruthenium, iridium and phosphine ruthenium complexes.
12th November 2014

Cross Coupling Fusion for Development and Application in Synthesis

This review constitutes a detailed but non-exhaustive examination of the directed ortho metalation (DoM) cross-coupling fusion in its many flavours.
12th November 2014

Emerging Trends in Homogeneous Hydrogenation Catalysis

Dr Antonio Zanotti-Gerosa and Dr Hans G Nedden of Johnson Matthey Catalysis and Chiral Technologies look at recent developments in...
12th November 2014

Handbook of Pharmaceutical Catalysis

This new edition of our technical handbook focuses on the latest catalytic technologies that drive processes in the pharmaceutical and...
12th November 2014
Quick Contact Johnson Matthey Fine Chemicals
Quick Contact Johnson Matthey Fine Chemicals

Contact Johnson Matthey Fine Chemicals

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact Johnson Matthey Fine Chemicals